Adding HIPEC to Cytoreductive Surgery Does Not Impact HRQOL in Ovarian Cancer
March 25, 2023 9:47 amby Hayley Virgil
Vadim Gushchin, MD, says that treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should not be limited by concerns of negatively impacting health-related quality of life in ovarian cancer.
Combining hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreductive surgery